MedPath

Impact of Time on Sexual Function (FSFI® Score) After Hysterectomy

Not Applicable
Not yet recruiting
Conditions
Sexual Function
Time Between Hysterectomy and Resumption of Sexual Relations
Interventions
Other: Recommended time after hysterectomy
Registration Number
NCT05728281
Lead Sponsor
University Hospital, Angers
Brief Summary

In France, more than 62 000 hysterectomies are performed each year. Female sexual function is the result of multiple psychological, social and physiological factors. There is no information in the current literature about the optimum time between the surgery and the sexual relation resumption. The primary outcome is to assess the impact of advising time between hysterectomy and sexual relation resumption by using FSFI® score. Secondaries outcomes are: to describe and compare post-operative complications in the two groups of the study, to describe the follow-up of the recommendation concerning time between surgery and sexual relation resumption and to describe why this recommendation was not followed. This study is based on 4 questionnaires: FSFI® pre-operative and post-operative, pre-operative questionnaire and post-operative questionnaire. This is a monocentric, comparative, of superiority, randomised and prospective study. Patients are randomised into two groups: sexual relation resumption advised 4 weeks after surgery, or 8 weeks. The inclusion criteria are more than 18 years, francophone, in sexual activity, scheduled for a total hysterectomy for benign indication (menometrorrhagia, fibroma, adenomyosis, endometriosis, pelvic floor disorders, low-grade endometrial cancer), considering vaginal, laparoscopic and abdominal approach, and a written consent. Non-inclusion criteria are illiteracy, cognitive disorders, without social security, deprived liberty by judicial or administrative decision, psychiatric care, patient with legal protection, patient incapable of giving consent. If our conclusions confirmed our hypothesis, it can improve clinical practices by providing additional informations for surgeon and patient, to undergo this surgery as serenely as possible.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
142
Inclusion Criteria
  • Patient ≥ 18 years old,

  • Francophone,

  • Sexually active,

  • Receiving a conservative or non-conservative total hysterectomy for benign pathology*,

  • Having signed a consent form. All surgical approaches are considered, laparoscopic approach with laparoscopic or vaginal closure, vaginal approach and laparotomy.

    *The indications for the procedure selected for this study include:

  • Menometrorrhagia,

  • Fibroids,

  • Adenomyosis,

  • Endometriosis,

  • Pelvic statics disorder,

  • Cervical dysplasia,

  • Endometrial cancer not requiring lymph node dissection or additional treatment.

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resumption of sexual intercourse recommended 4 weeks after hysterectomyRecommended time after hysterectomy-
Resumption of sexual intercourse recommended 8 weeks after hysterectomyRecommended time after hysterectomy-
Primary Outcome Measures
NameTimeMethod
The FSFI® scoreone year

Assessment of the impact of the recommended time between hysterectomy and resumption of sexual intercourse on sexual function using the FSFI® score

Secondary Outcome Measures
NameTimeMethod
Postoperative complicationsone year

Describe and compare postoperative complications according to the recommended time between hysterectomy and resumption of sexual intercourse. The postoperative complications studied include dyspareunia, spontaneous pain outside of sexual intercourse, metrorrhagia, infection, and vaginal fundal suture release.

Follow-up to the recommendationone year

Describe the follow-up to the recommendation in terms of time to resume sexual intercourse and describe the reasons for not following the recommendation

© Copyright 2025. All Rights Reserved by MedPath